Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Platelet count decreased? 732 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 732 reports of Platelet count decreased have been filed in association with GEMCITABINE (Gemcitabine). This represents 2.3% of all adverse event reports for GEMCITABINE.

732
Reports of Platelet count decreased with GEMCITABINE
2.3%
of all GEMCITABINE reports
105
Deaths
385
Hospitalizations

How Dangerous Is Platelet count decreased From GEMCITABINE?

Of the 732 reports, 105 (14.3%) resulted in death, 385 (52.6%) required hospitalization, and 145 (19.8%) were considered life-threatening.

Is Platelet count decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 732 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Platelet count decreased?

LENALIDOMIDE (7,491) NIRAPARIB (4,102) ELTROMBOPAG OLAMINE (3,419) RUXOLITINIB (3,028) RITUXIMAB (2,404) VENETOCLAX (2,367) DEXAMETHASONE (2,321) PALBOCICLIB (2,277) CYCLOPHOSPHAMIDE (1,894) RIBAVIRIN (1,701)

Which GEMCITABINE Alternatives Have Lower Platelet count decreased Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Platelet count decreased Reports All Drugs Causing Platelet count decreased GEMCITABINE Demographics